Can hydroxyurea serve as a free radical scavenger and reduce iron overload in β-thalassemia patients?

References

• Weatherall DJ, Clegg JB, eds. The thalassemia syndromes. 4th ed. Boston (MA): Blackwell Scientific Publications, Oxford University Press; 2001:100.
   Google Scholar
• Serjeant GR, Serjeant BE. Pathophysiology of sickle cell disease. In: Serjeant GR, Serjeant BE, eds. Sickle cell disease. New York: Oxford Medical Publications; 2001:71.
   Google Scholar
• Wood JC. Estimating tissue iron burden: current status and future prospects. Br J Haematol 2015;170:15–28.
   PubMed Web of Science ®Google Scholar
• Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 1995;332:1317–1322.
   PubMed Web of Science ®Google Scholar
• Bakanay SM, Dainer E, Clair B, Adekile A, Daitch L, Wells L, et al. Mortality in sickle cell patients on hydroxyurea therapy. Blood 2005;105:545–547.
   PubMed Web of Science ®Google Scholar
• Italia K, Jain D, Gattani S, Jijina F, Nadkarni A, Sawant P, et al. Hydroxyurea in sickle cell disease – a study of clinico-pharmacological efficacy in the Indian haplotype. Blood Cells Mol Dis 2009;42:25–31.
   PubMed Web of Science ®Google Scholar
• Fucharoen S, Siritanaratkul N, Winichagoon P, Chowthaworn J, Siriboon W, Muangsup W, et al. Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in β-thalassemia/hemoglobin E disease. Blood 1996;87:887–892.
   PubMed Web of Science ®Google Scholar
• Arruda VR, Lima CS, Saad ST, Costa FF. Successful use of hydroxyurea in beta-thalassemia major. N Engl J Med 1997;336:964.
   PubMed Web of Science ®Google Scholar
• Loukopoulos D, Voskaridou E, Stamoulakatou A, Papassotiriou Y, Kalotychou V, Loutradi A, et al. Hydroxyurea therapy in thalassemia. Ann NY Acad Sci 1998;850:120–128.
   PubMed Web of Science ®Google Scholar
• Alebouyeh M, Moussavi F, Haddad-Deylami H, Vossough P. Hydroxyurea in the treatment of major beta-thalassemia and importance of genetic screening. Ann Hematol 2004;83:430–433.
   PubMed Web of Science ®Google Scholar
• Italia KY, Jijina FJ, Merchant R, Panjwani S, Nadkarni AH, Sawant PM, et al. Response to hydroxyurea in beta thalassemia major and intermedia: experience in western India. Clin Chim Acta 2009;407:10–15.
   PubMed Web of Science ®Google Scholar
• Italia K, Jijina F, Merchant R, Panjwani S, Nadkarni AH, Sawant PM, et al. Effect of hydroxyurea on the transfusion requirements in patients with severe HbE-beta-thalassaemia: a genotypic and phenotypic study. J Clin Pathol 2010;63:147–150.
   PubMed Web of Science ®Google Scholar
• Nyholm S, Thelander L, Gräslund A. Reduction and loss of the iron center in the reaction of the small subunit of mouse ribonucleotide reductase with hydroxyurea. Biochemistry 1993;32:11569–11574.
   PubMed Web of Science ®Google Scholar
• Lou TF, Singh M, Mackie A, Li W, Pace BS. Hydroxyurea generates nitric oxide in human erythroid cells: mechanisms for gamma-globin gene activation. Exp Biol Med (Maywood) 2009;234:1374–1382.
   PubMed Web of Science ®Google Scholar
• Platt OS. Hydroxyurea for the treatment of sickle cell anemia. N Engl J Med 2008;358:1362–1369.
   PubMed Web of Science ®Google Scholar
• Italia K, Colah R, Ghosh K. Hydroxyurea could be a good clinically relevant iron chelator. PLoS One 2013;8:e82928.
   PubMed Web of Science ®Google Scholar
• Prus E, Fibach E. Flow cytometry measurement of the labile iron pool in human hematopoietic cells. Cytometry A 2008;73:22–27.
   PubMed Web of Science ®Google Scholar
• Barber LA, Palascak MB, Joiner CH, Franco R. Aminophospholipid translocase and phospholipid scramblase activities in sickle erythrocyte subpopulations. Br J Haematol 2009;146:447–455.
   PubMed Web of Science ®Google Scholar
• Amer J, Ghoti H, Rachmilewitz E, Koren A, Levin C, Fibach E. Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants. Br J Haematol 2005;132:108–113.
   Web of Science ®Google Scholar
• Colah RB, Gorakshakar AC, Lu CY, Nadkarni AH, Desai SN, Pawar AR, et al. Application of covalent reverse dot blot hybridisation for rapid prenatal diagnosis of the common Indian thalassemia syndromes. Ind J Hematol Blood Transf 1997;15:10–13.
   Google Scholar
• Old JM. DNA based diagnosis of the haemoglobin disorders. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, eds. Disorders of haemoglobin – genetics, pathophysiology and clinical management. Cambridge: Cambridge University Press; 2001:941–948.
   Google Scholar
• Tan AS, Quah TC, Low PS, Chong SS. A rapid and reliable 7-deletion multiplex polymerase chain reaction assay for alpha-thalassemia. Blood 2001;98:250–251.
   PubMed Web of Science ®Google Scholar
• Rifkind JM, Mohanty JG, Nagababu E. The pathophysiology of extracellular hemoglobin associated with enhanced oxidative reactions. Front Physiol 2014;5:500.
   PubMedGoogle Scholar
• van Zwieten R, Verhoeven AJ, Roos D. Inborn defects in the antioxidant systems of human red blood cells. Free Radic Biol Med 2014;67:377–386.
   PubMed Web of Science ®Google Scholar
• Voskou S, Aslan M, Fanis P, Phylactides M, Kleanthous M. Oxidative stress in β-thalassaemia and sickle cell disease. Redox Biol 2015;6:226–239.
   PubMed Web of Science ®Google Scholar
• Cabantchik ZI. Labile iron in cells and body fluids: physiology, pathology, and pharmacology. Front Pharmacol 2014;5:45.
   PubMed Web of Science ®Google Scholar
• Jacobs A. Low molecular weight intracellular iron transport compounds. Blood 1977;50:433–439.
   PubMed Web of Science ®Google Scholar
• Kruszewski M. Labile iron pool: the main determinant of cellular response to oxidative stress. Mutat Res 2003;531:81–92.
   PubMed Web of Science ®Google Scholar
• Lane DJ, Merlot AM, Huang ML, Bae DH, Jansson PJ, Sahni S, et al. Cellular iron uptake, trafficking and metabolism: key molecules and mechanisms and their roles in disease. Biochim Biophys Acta 2015;1853: 1130–1144.
   PubMed Web of Science ®Google Scholar
• Ganz T. Systemic iron homeostasis. Physiol Rev 2013;93:1721–1741.
   PubMed Web of Science ®Google Scholar
• Berdoukas V, Coates TD, Cabantchik ZI. Iron and oxidative stress in cardiomyopathy in thalassemia. Free Radic Biol Med 2015;88:3–9.
   PubMed Web of Science ®Google Scholar
• Barodka VM, Nagababu E, Mohanty JG, Nyhan D, Berkowitz DE, Rifkind JM, Strouse JJ. New insights provided by a comparison of impaired deformability with erythrocyte oxidative stress for sickle cell disease. Blood Cells Mol Dis 2014;52:230–235.
   PubMed Web of Science ®Google Scholar
• Ibrahim HA, Fouda MI, Yahya RS, Abousamra NK, Abd Elazim RA. Erythrocyte phosphatidylserine exposure in β-thalassemia. Lab Hematol 2014;20:9–14.
   PubMedGoogle Scholar
• Torres LS, Silva DG, Belini Junior E, de Almeida EA, Lobo CL, Cançado RD, et al. The influence of hydroxyurea on oxidative stress in sickle cell anemia. Rev Bras Hematol Hemoter 2012;34:421–425.
   PubMedGoogle Scholar
• Končić MZ, Barbarić M, Perković I, Zorc B. Antiradical, chelating and antioxidant activities of hydroxamic acids and hydroxyureas. Molecules 2011;16:6232–6242.
   PubMed Web of Science ®Google Scholar
• Konstantinou E, Pashalidis I, Kolnagou A, Kontoghiorghes GJ. Interactions of hydroxycarbamide (hydroxyurea) with iron and copper: implications on toxicity and therapeutic strategies. Hemoglobin 2011;35:237–246.
   PubMed Web of Science ®Google Scholar
• Kwiakowski JL. Oral iron chelators. Pediatr Clin N Am 2008;55:461–482
   PubMed Web of Science ®Google Scholar
• Shalev O, Repka T, Goldfarb A, Grinberg L, Abrahamov A, Olivieri NF, et al. Deferiprone (L1) chelates pathologic iron deposits from membranes of intact thalassemic and sickle red blood cells both in vitro and in vivo. Blood 1995;86:2008–2013.
   PubMed Web of Science ®Google Scholar
• Li H, Rybicki AC, Suzuka SM, von Bonsdorff L, Breuer W, Hall CB, et al. Transferrin therapy ameliorates disease in beta-thalassemic mice. Nat Med 2010;16:177–182.
   PubMed Web of Science ®Google Scholar